-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Gentex, Lowers Price Target to $25

Benzinga·07/09/2026 19:29:31
Listen to the news
UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $26 to $25.